Literature DB >> 18656361

Gait pattern in Duchenne muscular dystrophy.

Maria Grazia D'Angelo1, Matteo Berti, Luigi Piccinini, Marianna Romei, Michela Guglieri, Sara Bonato, Alessandro Degrate, Anna Carla Turconi, Nereo Bresolin.   

Abstract

We investigated the gait pattern of 21 patients with Duchenne muscular dystrophy (DMD), compared to 10 healthy controls through 3D Gait Analysis. An overall observation of gait pattern in our DMD patients when compared to controls confirmed the data previously reported for small dystrophic groups. An excessive anterior tilt of pelvis and abnormal knee pattern in loading response phase were found. Since during the swing phase the DMD foot is too plantarflexed, patients adopt a higher flexion and abduction of the hip in order to advance the swinging limb. Velocity and cadence of DMD patients resulted similar to those calculated for healthy subjects, whereas stride length was reduced and step width was increased. We then divided the DMD patients in to two subgroups (treated with steroids and untreated), and we observed that the only statistically significant differences between the two groups in Gait Analysis parameters were found for the maximum of ankle power. 3D Gait Analysis gives objective and quantitative information about the gait pattern and the deviations due to muscular situation of DMD subjects; being our study a single moment evaluation, it is otherwise unable to unravel changes only detectable through serial analysis during the time course of the disease and, if any, due to the treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656361     DOI: 10.1016/j.gaitpost.2008.06.002

Source DB:  PubMed          Journal:  Gait Posture        ISSN: 0966-6362            Impact factor:   2.840


  28 in total

Review 1.  Prevention and management of limb contractures in neuromuscular diseases.

Authors:  Andrew J Skalsky; Craig M McDonald
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

2.  Quantitative Evaluation of Muscle Function, Gait, and Postural Control in People Experiencing Critical Illness After Discharge From the Intensive Care Unit.

Authors:  Jeevaka B Kiriella; Tamara Araujo; Martin Vergara; Laura Lopez-Hernandez; Jill I Cameron; Margaret Herridge; William H Gage; Sunita Mathur
Journal:  Phys Ther       Date:  2018-01-01

3.  Classification of the gait patterns of boys with Duchenne muscular dystrophy and their relationship to function.

Authors:  Susan Sienko Thomas; Cathleen E Buckon; Alina Nicorici; Anita Bagley; Craig M McDonald; Michael D Sussman
Journal:  J Child Neurol       Date:  2010-06-29       Impact factor: 1.987

4.  Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.

Authors:  Claudia R Senesac; Donovan J Lott; Sean C Forbes; Sunita Mathur; Ishu Arpan; Emily S Senesac; Glenn A Walter; Krista Vandenborne
Journal:  Phys Ther       Date:  2015-01-15

5.  Relationship between clinical outcome measures and parent proxy reports of health-related quality of life in ambulatory children with Duchenne muscular dystrophy.

Authors:  Craig M McDonald; Dawn A McDonald; Anita Bagley; Susan Sienko Thomas; Cathleen E Buckon; Eric Henricson; Alina Nicorici; Michael D Sussman
Journal:  J Child Neurol       Date:  2010-06-17       Impact factor: 1.987

6.  Kinematics of gait in golden retriever muscular dystrophy.

Authors:  Anthony P Marsh; Joel D Eggebeen; Joe N Kornegay; Chad D Markert; Martin K Childers
Journal:  Neuromuscul Disord       Date:  2009-11-22       Impact factor: 4.296

Review 7.  Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.

Authors:  Omar Sheikh; Toshifumi Yokota
Journal:  BioDrugs       Date:  2021-06-07       Impact factor: 5.807

8.  T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy.

Authors:  Ishu Arpan; Sean C Forbes; Donovan J Lott; Claudia R Senesac; Michael J Daniels; William T Triplett; Jasjit K Deol; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  NMR Biomed       Date:  2012-10-09       Impact factor: 4.044

9.  The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures.

Authors:  Erik K Henricson; R Ted Abresch; Avital Cnaan; Fengming Hu; Tina Duong; Adrienne Arrieta; Jay Han; Diana M Escolar; Julaine M Florence; Paula R Clemens; Eric P Hoffman; Craig M McDonald
Journal:  Muscle Nerve       Date:  2013-05-06       Impact factor: 3.217

10.  Effects of lumbar lordosis increment on gait deteriorations in ambulant boys with Duchenne Muscular Dystrophy: A cross-sectional study.

Authors:  Meral Bilgilisoy Filiz; Naciye Füsun Toraman; Muhammet Gültekin Kutluk; Serkan Filiz; Şebnem Koldaş Doğan; Tuncay Çakır; Aylin Yaman
Journal:  Braz J Phys Ther       Date:  2021-05-24       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.